Page 1 | Search Results | Journal of Experimental Medicine

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

J C Skipper, R C Hendrickson, P H Gulden, V Brichard, A Van Pel, Y Chen, J Shabanowitz, T Wolfel, C L Slingluff, Jr, T Boon, D F Hunt, V H Engelhard

J Exp Med (1996) 183 (2): 527–534.

https://doi.org/10.1084/jem.183.2.527

Published: 01 February 1996

View article titled, An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Journal Articles

Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.

E Barzaga-Gilbert, D Grass, S K Lawrance, P A Peterson, E Lacy, V H Engelhard

J Exp Med (1992) 175 (6): 1707–1715.

https://doi.org/10.1084/jem.175.6.1707

Published: 01 June 1992

View article titled, Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.

Journal Articles

Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells.

E J Bernhard, A X Le, J A Barbosa, E Lacy, V H Engelhard

J Exp Med (1988) 168 (3): 1157–1162.

https://doi.org/10.1084/jem.168.3.1157

Published: 01 September 1988

View article titled, Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells.

Journal Articles

Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

K T Hogan, N Shimojo, S F Walk, V H Engelhard, W L Maloy, J E Coligan, W E Biddison

J Exp Med (1988) 168 (2): 725–736.

https://doi.org/10.1084/jem.168.2.725

Published: 01 August 1988

View article titled, Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

Journal Articles

Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms.

L S Gray, J Gnarra, E L Hewlett, V H Engelhard

J Exp Med (1988) 167 (6): 1963–1968.

https://doi.org/10.1084/jem.167.6.1963

Published: 01 June 1988

View article titled, Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms.

NARROW

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.

Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells.

Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms.

Email alerts

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.

Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.

Cytotoxic T lymphocytes from HLA-A2 transgenic mice specific for HLA-A2 expressed on human cells.

Mutations in the alpha 2 helix of HLA-A2 affect presentation but do not inhibit binding of influenza virus matrix peptide.

Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms.

Email alerts

This Feature Is Available To Subscribers Only